NeuroBioBank, Canada

Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper

Certification Status: Documents Required

Registration Status: Completed

Objective: This biobank project aims to establish a well-organized, prospective collection of biological samples obtained during routine clinical care from patients with neurological conditions. This resource will support research focused on the in-depth characterization of fluid-based biomarkers in individuals with multiple sclerosis (MS) and other central nervous system (CNS) inflammatory disorders. Findings will be contextualized through comparison with cerebrospinal fluid (CSF) samples from patients with both inflammatory and non-inflammatory neurological conditions.

Registered Biobank Name	NeuroBioBank
Biobank Leader	Dr. Giulia Fadda
Country	Canada
Email for biobank inquiries	gfadda@ohri.ca
Principal Investigator	Dr. Giulia Fadda, Dr. Mark Freedman
User Type Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper	Poly - Collection aimed at supporting undetermined, multiple users with ethics approved research projects, through a defined access/application mechanism.

Biospecimen Collected: